S. Shak
Impact in
- Cancer Research top 2%
- Breast Cancer Treatment Studies
- Cancer Genomics and Diagnostics
- Oncology top 2%
- HER2/EGFR in Cancer Research
- Colorectal Cancer Treatments and Studies
- Cancer Treatment and Pharmacology
Papers in
-
- Breast Cancer Treatment Studies 23
- Cancer Genomics and Diagnostics 9
- Oncology 19
- Cancer Treatment and Pharmacology 7
- HER2/EGFR in Cancer Research 6
- Co-authors
- George W. Sledge (3 shared papers)Daniel C. Adelman (1 shared paper)Eric Holmgren (1 shared paper)Michael S. Gordon (1 shared paper)Kim Margolin (1 shared paper)Robert S. Benjamin (1 shared paper)Moshe Talpaz (1 shared paper)Frederick L. Baehner (5 shared papers)
- Journals
- Cancer Research (14 papers)Journal of Clinical Oncology (13 papers)European Journal of Cancer (2 papers)Annals of Oncology (2 papers)The Breast (2 papers)
- Partner nations
- United StatesGermanySwitzerland
In The Last Decade
S. Shak
39 papers receiving 1.7k citations
S. Shak's Hit Papers
Peers
Comparison fields: 5 of 77
- Cancer Research 643
- Oncology 871
- Radiology, Nuclear Medicine and Imaging 235
- Hepatology 75
- Pulmonary and Respiratory Medicine 296
Countries citing papers authored by S. Shak
This map shows the geographic impact of S. Shak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Shak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Shak more than expected).
Fields of papers citing papers by S. Shak
This network shows the impact of papers produced by S. Shak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Shak. The network helps show where S. Shak may publish in the future.
Co-authors
The 25 scholars most cited alongside S. Shak, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 40 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Phase I Safety and Pharmacokinetic Study of Recombinant Human Anti-Vascular Endothelial Growth Factor in Patients With Advanced Cancer Hit paper breakdown → | 2001 | 746 |
| 2 | 2013 | 337 | |
| 3 | Overview of the trastuzumab (Herceptin) anti-HER2 monoclonal antibody clinical program in HER2-overexpressing metastatic breast cancer. Herceptin Multinational Investigator Study Group. | 1999 | 227 |
| 4 | 2010 | 93 | |
| 5 | 2011 | 80 | |
| 6 | 2006 | 80 | |
| 7 | 2009 | 25 | |
| 8 | 2009 | 24 | |
| 9 | 2020 | 20 | |
| 10 | 2012 | 19 | |
| 11 | 2014 | 17 | |
| 12 | 2009 | 14 | |
| 13 | 2010 | 11 | |
| 14 | 2010 | 10 | |
| 15 | 2016 | 9 | |
| 16 | 2004 | 9 | |
| 17 | 2010 | 8 | |
| 18 | 2008 | 8 | |
| 19 | 2004 | 6 | |
| 20 | Prospective WSG phase III PlanB trial: Clinical outcome at 5 year follow up and impact of 21 Gene Recurrence Score result, central/local-pathological review of grade, ER, PR and Ki67 in HR+/HER2-high risk node-negative and -positive breast cancer | 2016 | 5 |
About S. Shak
S. Shak is a scholar working on Cancer Research, Oncology, Pulmonary and Respiratory Medicine, Genetics and Molecular Biology, having authored 40 papers that have together received 1.8k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (23 papers), Advanced Breast Cancer Therapies (14 papers), Cancer Genomics and Diagnostics (9 papers), Cancer Treatment and Pharmacology (7 papers), HER2/EGFR in Cancer Research (6 papers), Molecular Biology Techniques and Applications (5 papers), Estrogen and related hormone effects (4 papers) and BRCA gene mutations in cancer (4 papers). The work is most often cited by research in Cancer Research (643 citations), Oncology (871 citations), Radiology, Nuclear Medicine and Imaging (235 citations), Hepatology (75 citations) and Pulmonary and Respiratory Medicine (296 citations). S. Shak has collaborated with scholars based in United States, Germany and Switzerland. Frequent co-authors include George W. Sledge, Daniel C. Adelman, Eric Holmgren, Michael S. Gordon, Kim Margolin, Robert S. Benjamin, Moshe Talpaz, Frederick L. Baehner, Nancy E. Davidson and G. W. Sledge. Their work appears in journals such as Cancer Research, Journal of Clinical Oncology, European Journal of Cancer, Annals of Oncology and The Breast.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.